Amandine Breton

Amandine Breton is an experienced professional in the field of cell and gene therapy, currently serving as Director of MSAT at Orchard Therapeutics since September 2019, where previous roles included Associate Director and Principal Scientist. Prior to this, Amandine held the position of Senior Scientific Officer at Cancer Research UK from January 2018 to September 2019 and worked as an Advanced Therapy Production Scientist at Guy's and St Thomas' NHS Foundation Trust from October 2016 to January 2018. Amandine's earlier experience includes research associate roles at King's College London and Queen Mary, University of London, as well as a postdoctoral scientist position at Roslin Institute, where research focused on induced pluripotent stem cells in equines. Amandine began the academic journey as a PhD student at INRA French National Institute for Agricultural Research, culminating in a PhD in Cellular and Molecular Biology from UVSQ Université de Versailles Saint-Quentin-en-Yvelines.